Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 11.17 0.02 (0.18%) Market Cap: 1.08 Bil Enterprise Value: 1.01 Bil PE Ratio: 0 PB Ratio: 14.41 GF Score: 40/100

Q1 2022 Avadel Pharmaceuticals PLC Earnings Call Transcript

May 09, 2022 / 12:30PM GMT
Release Date Price: $3.93 (-5.98%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Avadel Pharmaceuticals' First Quarter 2022 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker, Ms. Brandi Robinson, Senior Vice President of Corporate Affairs. Please go ahead.

Brandi Robinson
Avadel Pharmaceuticals plc - SVP of Corporate Affairs

Good morning, and thank you for joining us on our conference call. This morning, we issued our press release providing a corporate update and financial results for the first quarter ended March 31, 2022. The release can be found on our website, www.avadel.com.

As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements are subject to risks and uncertainties that could cause

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot